HeartSciences Inc. has secured an endorsement from Cibolo Rural Health Networks, a coalition of 123 independent hospitals in six states, to deploy its MyoVista Insights platform across the network. The platform will replace legacy ECG workflows, streamline data access, and enable AI‑driven decision support without disrupting existing processes.
The deal represents a pivotal commercial milestone for HeartSciences, a company that has historically reported minimal revenue and significant operating losses. While the financial terms of the partnership were not disclosed, the endorsement signals a potential source of recurring subscription revenue and a broader customer base that could accelerate the company’s path to regulatory clearance and market adoption.
MyoVista Insights is a device‑agnostic, cloud‑native ECG management system that supports a wide range of ECG devices and file formats. It also provides a scalable foundation for integrating regulatory‑compliant AI‑ECG algorithms directly into routine clinical practice, positioning HeartSciences to capture recurring subscription revenue from a geographically dispersed customer base.
Andrew Simpson, CEO of HeartSciences, said the partnership “represents an important step in expanding access to our MyoVista Insights platform across a broad network of independent hospitals.” He added that the collaboration will help the company “modernize legacy ECG workflows and improve data accessibility, ultimately enhancing clinical decision‑making.”
The partnership comes at a time when HeartSciences is pursuing FDA clearance for its wavECG device and a breakthrough designation for an aortic stenosis AI algorithm. The endorsement could provide a critical revenue stream and validate the company’s cloud‑based AI strategy, but the lack of disclosed financial terms and implementation timeline means the full impact remains uncertain. Nonetheless, the deal underscores the growing demand for AI‑enabled cardiac diagnostics in rural and independent hospital settings.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.